0001104659-24-039032.txt : 20240326 0001104659-24-039032.hdr.sgml : 20240326 20240326161537 ACCESSION NUMBER: 0001104659-24-039032 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240326 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Healthcare Trust, Inc. CENTRAL INDEX KEY: 0001561032 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 383888962 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39153 FILM NUMBER: 24783710 BUSINESS ADDRESS: STREET 1: 222 BELLEVUE AVENUE CITY: NEWPORT STATE: RI ZIP: 02840 BUSINESS PHONE: 212-415-6500 MAIL ADDRESS: STREET 1: 222 BELLEVUE AVENUE CITY: NEWPORT STATE: RI ZIP: 02840 FORMER COMPANY: FORMER CONFORMED NAME: American Realty Capital Healthcare Trust II, Inc. DATE OF NAME CHANGE: 20121025 8-K 1 tm249708d1_8k.htm FORM 8-K
false 0001561032 0001561032 2024-03-26 2024-03-26 0001561032 HTI:SeriesACumulativeRedeemablePerpetualPreferredStockMember 2024-03-26 2024-03-26 0001561032 HTI:SeriesBCumulativeRedeemablePerpetualPreferredStockMember 2024-03-26 2024-03-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):  March 26, 2024

 

Healthcare Trust, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Maryland  001-39153  38-3888962
(State or other jurisdiction
of incorporation)		  (Commission File Number)  (I.R.S. Employer
Identification No.)

 

222 Bellevue Ave.

Newport, RI 02840

(Address, including zip code, of Principal Executive Offices)

 

Registrant’s telephone number, including area code: (212) 415-6500

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:  Trading Symbol(s)  Name of each exchange on which registered:
7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share  HTIA  The Nasdaq Global Market
7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share  HTIBP  The Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

 Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ 

 

 

 

 

 

 

 Item 7.01 Regulation FD Disclosure.

 

Preferred Stock Dividends

 

On March 26, 2024, Healthcare Trust, Inc. (the “Company”) issued a press release announcing the declaration of a dividend of $0.4609375 per share payable on April 15, 2024 to holders of record of shares of the Company’s 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock at the close of business on April 5, 2024.

 

In addition, the Company announced the declaration of a dividend of $0.4453125 per share payable on April 15, 2024 to holders of record of shares of the Company’s 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock at the close of business on April 5, 2024.

 

A copy of the press release is attached as Exhibit 99.1, and is hereby incorporated by reference into this Item 7.01. The information contained in this Current Report on Form 8-K, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, except to the extent expressly stated in such filing.

 

Forward-Looking Statements

 

The statements in this Current Report on Form 8-K that are not historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words “anticipates,” “believes,” “expects,” “estimates,” “projects,” “plans,” “intends,” “may,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties and other factors, many of which are outside of the Company’s control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include the potential adverse effects of (i) a resurgence of the global COVID-19 pandemic, including actions taken to contain or treat COVID-19, (ii) the geopolitical instability due to the ongoing military conflict between Russia and Ukraine and Israel and Hamas, including related sanctions and other penalties imposed by the U.S. and European Union, and the related impact on the Company, the Company’s tenants, the Company’s operators and the global economy and financial markets, and (iii) inflationary conditions and higher interest rate environments, as well as those risks and uncertainties set forth in the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed on March 15, 2024, as amended by the Form 10-K/A filed on March 22, 2024, and all other filings with the Securities and Exchange Commission after that date, as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent filings with the Securities and Exchange Commission. Further, forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statement to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, unless required to do so by law.

 

 

 

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Press Release, dated March 26, 2024.
104   Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL

 

 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HEALTHCARE TRUST, INC.
     
Date: March 26, 2024 By: /s/ Scott M. Lappetito
    Scott M. Lappetito
    Chief Financial Officer, Secretary and Treasurer

 

 

 

 

 

 EX-99.1 2 tm249708d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

FOR IMMEDIATE RELEASE

 

Healthcare Trust

Announces Preferred Stock Dividends

 

New York, March 26, 2024 – Healthcare Trust, Inc. (Nasdaq: HTIA / HTIBP) (“HTI”) announced today that it intends to continue to pay dividends on a quarterly basis on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) at an annualized rate of $1.84375 per share or $0.4609375 per share on a quarterly basis. Dividends on the Series A Preferred Stock are payable in arrears to Series A Preferred Stock holders of record at the close of business on the applicable record date and payable on the 15th day of the first month of each fiscal quarter (or, if not a business day, the next succeeding business day).

 

Accordingly, HTI’s board of directors declared a dividend of $0.4609375 per share of Series A Preferred Stock payable on April 15, 2024 to Series A Preferred Stock holders of record at the close of business on April 5, 2024.

 

In addition, HTI announced today that it intends to continue to pay dividends on a quarterly basis on its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stock") at an annualized rate of $1.78125 per share or $0.4453125 per share on a quarterly basis. Dividends on the Series B Preferred Stock are payable in arrears to Series B Preferred Stock holders of record at the close of business on the applicable record date and payable on the 15th day of the first month of each fiscal quarter (or, if not a business day, the next succeeding business day).

 

Accordingly, HTI’s board of directors declared a dividend of $0.4453125 per share of Series B Preferred Stock payable on April 15, 2024, to Series B Preferred Stock holders of record at the close of business on April 5, 2024.

 

About Healthcare Trust, Inc.

 

Healthcare Trust, Inc. (Nasdaq: HTIA/HTIBP) is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing and medical office buildings, located in the United States. Additional information about HTI can be found on its website at www.healthcaretrustinc.com.

 

Important Notice

 

The statements in this press release that are not historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words “anticipates,” “believes,” “expects,” “estimates,” “projects,” “plans,” “intends,” “may,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties and other factors, many of which are outside of HTI’s control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include the potential adverse effects of (i) a resurgence of the global COVID-19 pandemic, including actions taken to contain or treat COVID-19, (ii) the geopolitical instability due to the ongoing military conflict between Russia and Ukraine and Israel and Hamas, including related sanctions and other penalties imposed by the U.S. and European Union, and the related impact on HTI, HTI’s tenants, HTI’s operators and the global economy and financial markets, and (iii) inflationary conditions and higher interest rate environments, as well as those risks and uncertainties set forth in the Risk Factors section of HTI’s Annual Report on Form 10-K for the year ended December 31, 2023 filed on March 15, 2024, as amended by the Form 10-K/A filed on March 22, 2024, and all other filings with the Securities and Exchange Commission after that date, as such risks, uncertainties and other important factors may be updated from time to time in HTI’s subsequent filings with the Securities and Exchange Commission. Further, forward-looking statements speak only as of the date they are made, and HTI undertakes no obligation to update or revise any forward-looking statement to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, unless required to do so by law.

 

 

 

 

Contact

 

Investors and Media:

Email: investorrelations@ar-global.com

Phone: (866) 902-0063

 

 

 

 EX-101.SCH 3 hti-20240326.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 hti-20240326_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 hti-20240326_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Axis] Series A Cumulative Redeemable Perpetual Preferred Stock [Member] Series B Cumulative Redeemable Perpetual Preferred Stock [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 hti-20240326_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 image_001.jpg GRAPHIC begin 644 image_001.jpg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end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
Mar. 26, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 26, 2024
Entity File Number 001-39153
Entity Registrant Name Healthcare Trust, Inc.
Entity Central Index Key 0001561032
Entity Tax Identification Number 38-3888962
Entity Incorporation, State or Country Code MD
Entity Address, Address Line One 222 Bellevue Ave
Entity Address, City or Town Newport
Entity Address, State or Province RI
Entity Address, Postal Zip Code 02840
City Area Code 212
Local Phone Number 415-6500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Series A Cumulative Redeemable Perpetual Preferred Stock [Member]  
Title of 12(b) Security 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share
Trading Symbol HTIA
Security Exchange Name NASDAQ
Series B Cumulative Redeemable Perpetual Preferred Stock [Member]  
Title of 12(b) Security 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share
Trading Symbol HTIBP
Security Exchange Name NASDAQ

EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 3 22 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://thehealthcarereit2.com/role/Cover Cover Cover 1 false false All Reports Book All Reports hti-20240326.xsd hti-20240326_def.xml hti-20240326_lab.xml hti-20240326_pre.xml tm249708d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm249708d1_8k.htm": { "nsprefix": "HTI", "nsuri": "http://thehealthcarereit2.com/20240326", "dts": { "schema": { "local": [ "hti-20240326.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "hti-20240326_def.xml" ] }, "labelLink": { "local": [ "hti-20240326_lab.xml" ] }, "presentationLink": { "local": [ "hti-20240326_pre.xml" ] }, "inline": { "local": [ "tm249708d1_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "report": { "R1": { "role": "http://thehealthcarereit2.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm249708d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm249708d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "HTI_SeriesACumulativeRedeemablePerpetualPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://thehealthcarereit2.com/20240326", "localname": "SeriesACumulativeRedeemablePerpetualPreferredStockMember", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Series A Cumulative Redeemable Perpetual Preferred Stock [Member]" } } }, "auth_ref": [] }, "HTI_SeriesBCumulativeRedeemablePerpetualPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://thehealthcarereit2.com/20240326", "localname": "SeriesBCumulativeRedeemablePerpetualPreferredStockMember", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Series B Cumulative Redeemable Perpetual Preferred Stock [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001104659-24-039032-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-039032-xbrl.zip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end XML 19 tm249708d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001561032 2024-03-26 2024-03-26 0001561032 HTI:SeriesACumulativeRedeemablePerpetualPreferredStockMember 2024-03-26 2024-03-26 0001561032 HTI:SeriesBCumulativeRedeemablePerpetualPreferredStockMember 2024-03-26 2024-03-26 iso4217:USD shares iso4217:USD shares false 0001561032 8-K 2024-03-26 Healthcare Trust, Inc. MD 001-39153 38-3888962 222 Bellevue Ave Newport RI 02840 212 415-6500 false false false false 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share HTIA NASDAQ 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share HTIBP NASDAQ false